149 related articles for article (PubMed ID: 9882368)
1. Identification of directly infected cells in the bone marrow of neonatal moloney murine leukemia virus-infected mice by use of a moloney murine leukemia virus-based vector.
Okimoto MA; Fan H
J Virol; 1999 Feb; 73(2):1617-23. PubMed ID: 9882368
[TBL] [Abstract][Full Text] [Related]
2. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
Atencio IA; Belli B; Hobbs M; Cheng SF; Villarreal LP; Fan H
Virology; 1995 Oct; 212(2):356-66. PubMed ID: 7571405
[TBL] [Abstract][Full Text] [Related]
3. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
[TBL] [Abstract][Full Text] [Related]
4. ZASC1 knockout mice exhibit an early bone marrow-specific defect in murine leukemia virus replication.
Seidel S; Bruce J; Leblanc M; Lee KF; Fan H; Ahlquist P; Young JA
Virol J; 2013 Apr; 10():130. PubMed ID: 23617998
[TBL] [Abstract][Full Text] [Related]
5. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.
Belli B; Patel A; Fan H
J Virol; 1995 Feb; 69(2):1037-43. PubMed ID: 7815481
[TBL] [Abstract][Full Text] [Related]
6. Appearance of mink cell focus-inducing recombinants during in vivo infection by moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesis.
Lander JK; Chesebro B; Fan H
J Virol; 1999 Jul; 73(7):5671-80. PubMed ID: 10364317
[TBL] [Abstract][Full Text] [Related]
7. The leukemogenic potential of an enhancer variant of Moloney murine leukemia virus varies with the route of inoculation.
Belli B; Fan H
J Virol; 1994 Nov; 68(11):6883-9. PubMed ID: 7933068
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of a recombinant Moloney murine leukemia virus containing the v-myc oncogene of avian MC29 virus: in vitro transformation and in vivo pathogenesis.
Brightman BK; Pattengale PK; Fan H
J Virol; 1986 Oct; 60(1):68-81. PubMed ID: 3018301
[TBL] [Abstract][Full Text] [Related]
9. Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene.
Low A; Okeoma CM; Lovsin N; de las Heras M; Taylor TH; Peterlin BM; Ross SR; Fan H
Virology; 2009 Mar; 385(2):455-63. PubMed ID: 19150103
[TBL] [Abstract][Full Text] [Related]
10. Moloney murine leukemia virus infects cells of the developing hair follicle after neonatal subcutaneous inoculation in mice.
Okimoto MA; Fan H
J Virol; 1999 Mar; 73(3):2509-16. PubMed ID: 9971836
[TBL] [Abstract][Full Text] [Related]
11. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
Brightman BK; Farmer C; Fan H
J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
[TBL] [Abstract][Full Text] [Related]
12. Leukaemogenesis by the delta Mo + SV Moloney murine leukaemia virus (M-MuLV) variant in E mu pim-1 transgenic mice: high frequency of recombination with a solo endogenous M-MuLV LTR in vivo.
Suchman EL; Pattengale PK; Fan H
J Gen Virol; 1995 Feb; 76 ( Pt 2)():347-56. PubMed ID: 7844555
[TBL] [Abstract][Full Text] [Related]
13. Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line.
Hartley JW; Evans LH; Green KY; Naghashfar Z; Macias AR; Zerfas PM; Ward JM
Retrovirology; 2008 Jan; 5():1. PubMed ID: 18177500
[TBL] [Abstract][Full Text] [Related]
14. Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties.
Audit M; Déjardin J; Hohl B; Sidobre C; Hope TJ; Mougel M; Sitbon M
J Virol; 1999 Dec; 73(12):10472-9. PubMed ID: 10559365
[TBL] [Abstract][Full Text] [Related]
15. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
16. A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference.
Lavignon M; Evans L
J Virol; 1996 Jun; 70(6):3852-62. PubMed ID: 8648721
[TBL] [Abstract][Full Text] [Related]
17. Moloney murine leukemia virus-induced preleukemic thymic atrophy and enhanced thymocyte apoptosis correlate with disease pathogenicity.
Bonzon C; Fan H
J Virol; 1999 Mar; 73(3):2434-41. PubMed ID: 9971828
[TBL] [Abstract][Full Text] [Related]
18. Important role of the long terminal repeat of the helper Moloney murine leukemia virus in Abelson virus-induced lymphoma.
Savard P; DesGroseillers L; Rassart E; Poirier Y; Jolicoeur P
J Virol; 1987 Oct; 61(10):3266-75. PubMed ID: 3041046
[TBL] [Abstract][Full Text] [Related]
19. Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus.
Rulli K; Lenz J; Levy LS
J Virol; 2002 Mar; 76(5):2363-74. PubMed ID: 11836414
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
Nazarov V; Hilbert D; Wolff L
Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
